Share Purchases by Directors

RNS Number : 6582J

Redx Pharma plc

23 December 2020

 

REDX PHARMA PLC

("Redx" or "the Company")

Share Purchases by Directors

Alderley Park, 23 December 2020 - Redx Pharma (AIM:REDX), the drug discovery and development Group focused on cancer and fibrosis, announces that it has been notified that Lisa Anson, Chief Executive Officer, has on Tuesday 22 December acquired 39,998 Redx ordinary shares at the following prices: 

Number of Ordinary shares purchased	Price per share (pence)
39,998	50p

Following this, Mrs Anson will hold 129,284 ordinary shares in the Company, representing 0.05 per cent. of the issued share capital.

-Ends-

For further information, please contact:

Redx Pharma Plc	T: [phone]
Lisa Anson, Chief Executive Officer James Mead, Chief Financial Officer
SPARK Advisory Partners (Nominated Advisor)	T: [phone]
Matt Davis/ Adam Dawes
WG Partners LLP (Broker)	T: [phone]
Claes Spång/ Chris Lee/ David Wilson
FTI Consulting	T: [phone]
Simon Conway/Ciara Martin

About Redx Pharma Plc 

Redx is a UK biotechnology Group whose shares are traded on AIM (AIM:REDX). Redx is focused on creating and developing first, or potentially best in class drugs, in specific areas of cancer and fibrosis that address significant unmet medical need. Redx has an in-house discovery team with proven world-class chemistry capabilities.

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1	Details of the person discharging managerial responsibilities/person closely associated
a.	Name	Lisa Anson
2	Reason for notification
a.	Position/Status	Chief Executive
b.	Initial notification/ Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.	Name	Redx Pharma Plc
b.	LEI	213800HMS4EBXO589Y37
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.	Description of the financial instrument, type of instrument Identification Code	Ordinary Shares of 1p each ISIN: GB00BSNB6S51
b.	Nature of the transaction	Purchase
c.	Price(s) and volume(s)	39,998 at 50 pence per share
d.	Aggregated information - Aggregated Volume - Price	39,998 at 50 pence per share
e.	Date of the transaction	22/12/20
f.	Place of the transaction	Outside of trading venue

 

END

 

 

DSHFIFVTFVLVFII